136 related articles for article (PubMed ID: 19424409)
1. [Corticosteroid refractory colonic Crohn disease with successful remission with infliximab].
Alva E; Vásquez J; Frisancho O; Mantilla L; Yábar A; Morales D
Rev Gastroenterol Peru; 2009; 29(1):51-4. PubMed ID: 19424409
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of infliximab in Brazilian children and adolescents with Crohn disease and ulcerative colitis according to clinical manifestations, activity indices of inflammatory bowel disease, and corticosteroid use.
Tiemi J; Komati S; Sdepanian VL
J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):628-33. PubMed ID: 20386321
[TBL] [Abstract][Full Text] [Related]
3. [Management of colonic Crohn disease with no response to corticoids and sulfazalazine: first case of pediatric use of infliximab in Peru].
Muñoz Urribarri A; Sylvester F; Delgado Godos A; Castillo Durán R
Rev Gastroenterol Peru; 2013; 33(2):162-6. PubMed ID: 23838945
[TBL] [Abstract][Full Text] [Related]
4. Crohn disease or intestinal fistulising tuberculosis? Diagnosis difficulties in a case treated with infliximab and corticosteroids.
Cazacu S; Vere CC; Comănescu V; Dumitrescu C; Enache SD; Ciurea T
Rom J Morphol Embryol; 2009; 50(2):263-8. PubMed ID: 19434321
[TBL] [Abstract][Full Text] [Related]
5. 12-month follow-up after successful infliximab therapy in pediatric crohn disease.
Wynands J; Belbouab R; Candon S; Talbotec C; Mougenot JF; Chatenoud L; Schmitz J; Cézard JP; Goulet O; Hugot JP; Ruemmele FM
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):293-8. PubMed ID: 18376247
[TBL] [Abstract][Full Text] [Related]
6. Infliximab as first-line therapy in severe pediatric Crohn disease.
de Ridder L; Benninga MA; Taminiau JA; Hommes DW
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):388-90. PubMed ID: 16954965
[No Abstract] [Full Text] [Related]
7. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
Yamamoto-Furusho JK; Uzcanga LF
Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of premedication with intravenous corticosteroids and antihistaminics in preventing infusion reactions to infliximab].
Bermejo F; López San Román A; Algaba A; van Domselaar M; Carneros JA; Rivero M; Piqueras B; Valer MP
Gastroenterol Hepatol; 2008 Dec; 31(10):629-32. PubMed ID: 19174078
[TBL] [Abstract][Full Text] [Related]
9. Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACH.
Crandall W; Hyams J; Kugathasan S; Griffiths A; Zrubek J; Olson A; Liu G; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano RN
J Pediatr Gastroenterol Nutr; 2009 Aug; 49(2):183-90. PubMed ID: 19561542
[TBL] [Abstract][Full Text] [Related]
10. Use of corticosteroids, immunomodulators, and infliximab at a third-level Day-Hospital Service of Gastro-Hepatology.
Actis GC; Pellicano R; Bugianesi E; Lagget M; Rizzetto M
Minerva Gastroenterol Dietol; 2008 Sep; 54(3):239-42. PubMed ID: 18614972
[TBL] [Abstract][Full Text] [Related]
11. Metastatic vulval Crohn's disease and infliximab: a case report.
Tritton SM; Whyte L; Fischer G
J Reprod Med; 2009 Jan; 54(1):41-4. PubMed ID: 19263879
[TBL] [Abstract][Full Text] [Related]
12. Treatment with infliximab in a patient with ankylosing spondylitis and Crohn's disease.
Rednic S; Marinescu C; Chira R; Rogojan L; Rednic N
J Gastrointestin Liver Dis; 2006 Dec; 15(4):379-82. PubMed ID: 17205151
[TBL] [Abstract][Full Text] [Related]
13. Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms.
Pfefferkorn M; Burke G; Griffiths A; Markowitz J; Rosh J; Mack D; Otley A; Kugathasan S; Evans J; Bousvaros A; Moyer MS; Wyllie R; Oliva-Hemker M; Carvalho R; Crandall W; Keljo D; Walters TD; LeLeiko N; Hyams J
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):168-74. PubMed ID: 19179878
[TBL] [Abstract][Full Text] [Related]
14. Dramatic MRI improvement with refractory neurosarcoidosis treated with infliximab.
Toth C; Martin L; Morrish W; Coutts S; Parney I
Acta Neurol Scand; 2007 Oct; 116(4):259-62. PubMed ID: 17824906
[TBL] [Abstract][Full Text] [Related]
15. Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study.
Thayu M; Leonard MB; Hyams JS; Crandall WV; Kugathasan S; Otley AR; Olson A; Johanns J; Marano CW; Heuschkel RB; Veereman-Wauters G; Griffiths AM; Baldassano RN;
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1378-84. PubMed ID: 19081527
[TBL] [Abstract][Full Text] [Related]
16. [Refractory neurosarcoidosis and infliximab: a growing experience].
Ritzenthaler T; Gonzalez-Martinez V; Guegen A; Tilikete C; Vighetto A
Rev Neurol (Paris); 2009 Feb; 165(2):197-200. PubMed ID: 18653204
[TBL] [Abstract][Full Text] [Related]
17. [Response to stopping azathioprine in Crohn's patients on combined treatment with infliximab].
Martín De Carpi J; Varea V
An Pediatr (Barc); 2009 Mar; 70(3):271-7. PubMed ID: 19409244
[TBL] [Abstract][Full Text] [Related]
18. A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment.
Arend SM; Leyten EM; Franken WP; Huisman EM; van Dissel JT
Clin Infect Dis; 2007 Dec; 45(11):1470-5. PubMed ID: 17990230
[TBL] [Abstract][Full Text] [Related]
19. Takayasu's aortitis and infliximab.
El-Matary W; Persad R
J Pediatr; 2009 Jul; 155(1):151. PubMed ID: 19559311
[No Abstract] [Full Text] [Related]
20. Infliximab-induced disseminated histoplasmosis in a patient with Crohn's disease.
Galandiuk S; Davis BR
Nat Clin Pract Gastroenterol Hepatol; 2008 May; 5(5):283-7. PubMed ID: 18398409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
